<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Clofazimin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:45 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Clofazimin_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Clofazimin_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Clofazimin_files/filelist.xml">
<title>CLOFAZIMIN</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>lylv</o:LastAuthor>
  <o:Revision>5</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:Created>2006-08-08T14:02:00Z</o:Created>
  <o:LastSaved>2006-08-09T05:19:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>1075</o:Words>
  <o:Characters>6131</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>51</o:Lines>
  <o:Paragraphs>14</o:Paragraphs>
  <o:CharactersWithSpaces>7192</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>CLOFAZIMIN<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tên
chung qu&#7889;c t&#7871;</span></b><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'>: Clofazimine.<b><o:p></o:p></b></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Mã ATC:</span></b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> J04B
A01.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Lo&#7841;i
thu&#7889;c</span></b><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>: Thu&#7889;c tr&#7883; phong.<b><span style='mso-tab-count:
1'>   </span><o:p></o:p></b></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng
thu&#7889;c và hàm l&#432;&#7907;ng</span></b><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'><o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Viên
nang 50 mg, 100 mg.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
lý và c&#417; ch&#7871; tác d&#7909;ng <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Clofazimin
thu&#7897;c nhóm thu&#7889;c nhu&#7897;m phenazin, có tác d&#7909;ng ch&#7889;ng
viêm và ch&#7889;ng <i>Mycobacterium</i>. C&#417; ch&#7871; tác d&#7909;ng c&#7911;a
clofazimin trên <i>Mycobacterium</i> ch&#432;a &#273;&#432;&#7907;c bi&#7871;t
rõ. Thu&#7889;c liên k&#7871;t &#432;u tiên v&#7899;i DNA và &#7913;c ch&#7871;
s&#7921; sao chép và phát tri&#7875;n c&#7911;a <i>Mycobacterium</i>. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>In vivo,
clofazimin có tác d&#7909;ng di&#7879;t khu&#7849;n ch&#7853;m &#273;&#7889;i v&#7899;i
vi khu&#7849;n b&#7879;nh phong <i>Mycobacterium leprae</i>, tuy nhiên, khó
&#273;ánh giá tác d&#7909;ng c&#7911;a thu&#7889;c trên vi khu&#7849;n, vì
ch&#432;a th&#7875; nuôi c&#7845;y &#273;&#432;&#7907;c vi khu&#7849;n b&#7879;nh
phong in vitro.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Clofazimin
có tác d&#7909;ng ch&#7889;ng viêm và mi&#7877;n d&#7883;ch c&#7843; in vitro
và in vivo, tuy c&#417; ch&#7871; chính xác c&#7911;a các tác d&#7909;ng
&#273;ó ch&#432;a &#273;&#432;&#7907;c bi&#7871;t &#273;&#7847;y &#273;&#7911;.
In vitro, clofazimin &#7913;c ch&#7871; s&#7921; di chuy&#7875;n b&#7841;ch c&#7847;u
trung tính (s&#7921; &#7913;c ch&#7871; này t&#259;ng d&#7847;n lên và ph&#7909;
thu&#7897;c li&#7873;u dùng) và &#7913;c ch&#7871; s&#7921; chuy&#7875;n d&#7841;ng
lympho bào do ch&#7845;t gây gián phân. Tác d&#7909;ng ch&#7889;ng viêm và &#7913;c
ch&#7871; mi&#7877;n d&#7883;ch c&#7911;a clofazimin cùng v&#7899;i tác d&#7909;ng
ch&#7889;ng <i>Mycobacterium</i> &#273;óng góp rõ ràng vào hi&#7879;u qu&#7843;
c&#7911;a thu&#7889;c trong &#273;i&#7873;u tr&#7883; và phòng ph&#7843;n &#7913;ng
ban &#273;&#7887; nút do b&#7879;nh phong.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ít th&#7845;y
thông báo <i>Mycobacterium leprae</i> kháng l&#7841;i clofazimin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
&#273;&#7897;ng h&#7885;c</span></i><b><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'> <o:p></o:p></span></b></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Clofazimin
&#273;&#432;&#7907;c h&#7845;p thu không hoàn toàn qua &#273;&#432;&#7901;ng
tiêu hóa sau khi u&#7889;ng. Sinh kh&#7843; d&#7909;ng thay &#273;&#7893;i nhi&#7873;u
gi&#7919;a các cá th&#7875; và ph&#7909; thu&#7897;c vào nhi&#7873;u y&#7871;u
t&#7889; nh&#432; kích th&#432;&#7899;c h&#7841;t thu&#7889;c, d&#7841;ng thu&#7889;c,
li&#7873;u dùng và có hay không có th&#7913;c &#259;n trong &#273;&#432;&#7901;ng
tiêu hóa. (S&#7921; có m&#7863;t c&#7911;a th&#7913;c &#259;n trong
&#273;&#432;&#7901;ng tiêu hóa có th&#7875; làm t&#259;ng t&#7889;c &#273;&#7897;
và m&#7913;c &#273;&#7897; h&#7845;p thu). <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ng&#432;&#7901;i
kho&#7867; m&#7841;nh u&#7889;ng m&#7897;t li&#7873;u 200 mg clofazimin, n&#7891;ng
&#273;&#7897; &#273;&#7881;nh trong huy&#7871;t t&#432;&#417;ng &#273;&#7841;t
&#273;&#432;&#7907;c sau 4 - 12 gi&#7901;. K&#7871;t qu&#7843; nghiên c&#7913;u
u&#7889;ng nhi&#7873;u li&#7873;u cho th&#7845;y, ch&#7881; có th&#7875; &#273;&#7841;t
&#273;&#432;&#7907;c n&#7891;ng &#273;&#7897; thu&#7889;c &#7893;n &#273;&#7883;nh
trong huy&#7871;t t&#432;&#417;ng sau ít nh&#7845;t 30 ngày &#273;i&#7873;u tr&#7883;.
Ng&#432;&#7901;i b&#7879;nh phong u&#7889;ng clofazimin li&#7873;u 100 ho&#7863;c
300 mg m&#7897;t l&#7847;n hàng ngày, n&#7891;ng &#273;&#7897; trung bình &#7893;n
&#273;&#7883;nh trong huy&#7871;t t&#432;&#417;ng t&#432;&#417;ng &#7913;ng là
0,7 ho&#7863;c 1 microgam/ml. Tuy nhiên, m&#7889;i quan h&#7879; gi&#7919;a n&#7891;ng
&#273;&#7897; clofazimin và tác d&#7909;ng &#273;i&#7873;u tr&#7883; c&#7911;a
thu&#7889;c v&#7851;n ch&#432;a &#273;&#432;&#7907;c xác &#273;&#7883;nh.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Clofazimin
là ch&#7845;t r&#7845;t &#432;a m&#7905;, nên &#273;&#432;&#7907;c phân b&#7889;
ch&#7911; y&#7871;u vào mô m&#7905; và t&#7871; bào h&#7879; l&#432;&#7899;i n&#7897;i
mô. Thu&#7889;c qua nhau thai, ti&#7871;t &#273;&#432;&#7907;c vào s&#7919;a và
không phân b&#7889; vào não và d&#7883;ch não t&#7911;y. Sau khi u&#7889;ng m&#7897;t
li&#7873;u clofazimin, n&#7917;a &#273;&#7901;i th&#7843;i tr&#7915; pha cu&#7889;i
kho&#7843;ng 8 ngày. Clofazimin bài ti&#7871;t ch&#7911; y&#7871;u qua phân, c&#7843;
ph&#7847;n không h&#7845;p thu, c&#7843; ph&#7847;n th&#7843;i tr&#7915; qua m&#7853;t.
Thu&#7889;c ch&#7881; bài ti&#7871;t qua n&#432;&#7899;c ti&#7875;u v&#7899;i
l&#432;&#7907;ng nh&#7887;. M&#7897;t l&#432;&#7907;ng nh&#7887; c&#361;ng bài
ti&#7871;t qua tuy&#7871;n bã nh&#7901;n và tuy&#7871;n m&#7891; hôi.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881;
&#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7879;nh
phong: Dùng clofazimin ph&#7889;i h&#7907;p v&#7899;i ít nh&#7845;t m&#7897;t
thu&#7889;c kháng khu&#7849;n khác &#273;&#7875; &#273;i&#7873;u tr&#7883; b&#7879;nh
phong &#273;a khu&#7849;n k&#7875; c&#7843; b&#7879;nh phong u, b&#7879;nh
phong u kháng dapson và b&#7879;nh phong u có bi&#7871;n ch&#7913;ng thành
phong u ban &#273;&#7887;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Nhi&#7877;m
ph&#7913;c h&#7907;p <i>Mycobacterium avium </i>(MAC): Clofazimin &#273;ã
&#273;&#432;&#7907;c dùng trong m&#7897;t phác &#273;&#7891; &#273;i&#7873;u tr&#7883;
g&#7891;m nhi&#7873;u thu&#7889;c &#273;&#7875; &#273;i&#7873;u tr&#7883; nhi&#7877;m
ph&#7913;c h&#7907;p <i>Mycobacterium avium</i> &#7903; ph&#7893;i và ngoài ph&#7893;i.
Tuy v&#7853;y, hi&#7879;n nay nhi&#7877;m khu&#7849;n &#273;ó &#273;&#432;&#7907;c
khuy&#7871;n cáo &#273;i&#7873;u tr&#7883; theo m&#7897;t phác &#273;&#7891;
dùng macrolid bao g&#7891;m ít nh&#7845;t 3 thu&#7889;c (thí d&#7909;
clarithromycin ho&#7863;c azithromycin, rifabutin ho&#7863;c rifampin, và
ethambutol).<b><o:p></o:p></b></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng
ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>M&#7851;n
c&#7843;m v&#7899;i clofazimin.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n
tr&#7885;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n
tr&#7885;ng v&#7899;i ng&#432;&#7901;i b&#7879;nh có tri&#7879;u ch&#7913;ng
tiêu hóa nh&#432; &#273;au b&#7909;ng, &#7881;a ch&#7843;y. N&#7871;u ng&#432;&#7901;i
b&#7879;nh b&#7883; &#273;au b&#7909;ng nóng rát, bu&#7891;n nôn, nôn, &#7881;a
ch&#7843;y khi &#273;i&#7873;u tr&#7883; b&#7857;ng clofazimin, thì nên gi&#7843;m
li&#7873;u và n&#7871;u c&#7847;n, t&#259;ng kho&#7843;ng cách th&#7901;i gian
u&#7889;ng thu&#7889;c ho&#7863;c ng&#7915;ng thu&#7889;c.<b><o:p></o:p></b></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>An toàn
và hi&#7879;u qu&#7843; c&#7911;a clofazimin &#7903; tr&#7867; em d&#432;&#7899;i
12 tu&#7893;i ch&#432;a &#273;&#432;&#7907;c xác &#273;&#7883;nh. Thu&#7889;c
&#273;ã &#273;&#432;&#7907;c dùng cho m&#7897;t s&#7889; ít tr&#7867; em.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ng&#432;&#7901;i
b&#7879;nh dùng clofazimin ph&#7843;i &#273;&#432;&#7907;c thông báo thu&#7889;c
có th&#7875; gây &#273;&#7893;i màu t&#7915; h&#7891;ng sang nâu &#273;en &#7903;
da c&#361;ng nh&#432; &#7903; k&#7871;t m&#7841;c, n&#432;&#7899;c m&#7855;t, m&#7891;
hôi, &#273;&#7901;m, n&#432;&#7899;c ti&#7875;u, phân, n&#432;&#7899;c m&#361;i,
tinh d&#7883;ch và s&#7919;a. Ph&#7843;i khuyên ng&#432;&#7901;i b&#7879;nh là
hi&#7879;n t&#432;&#7907;ng &#273;&#7893;i màu da tuy có h&#7891;i ph&#7909;c
nh&#432;ng có th&#7875; ph&#7843;i m&#7845;t vài tháng ho&#7863;c vài n&#259;m
sau khi ng&#7915;ng dùng clofazimin.<b><o:p></o:p></b></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; mang thai <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Clofazimin
qua nhau thai và da c&#7911;a m&#7897;t s&#7889; tr&#7867; m&#7899;i sinh b&#7883;
&#273;&#7893;i màu. Da &#273;&#7893;i màu nh&#7841;t d&#7847;n trong n&#259;m
&#273;&#7847;u. M&#7897;t vài tr&#7867; &#273;&#7867; ra &#273;ã ch&#7871;t,
nh&#432;ng liên quan nhân qu&#7843; v&#7899;i clofazimin ch&#432;a &#273;&#432;&#7907;c
xác &#273;&#7883;nh. Do &#273;ó, thu&#7889;c ch&#7881; dùng cho ng&#432;&#7901;i
mang thai khi xét th&#7845;y l&#7907;i ích l&#7899;n h&#417;n nguy c&#417; có
th&#7875; có cho thai nhi.<b><o:p></o:p></b></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; cho con bú<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Clofazimin
bài ti&#7871;t vào s&#7919;a và da c&#7911;a tr&#7867; bú m&#7865; có th&#7875;
b&#7883; &#273;&#7893;i màu. Do v&#7853;y ch&#7881; dùng thu&#7889;c cho bà m&#7865;
cho con bú khi có ch&#7881; &#273;&#7883;nh rõ ràng.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tác
d&#7909;ng không mong mu&#7889;n (ADR)<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Clofazimin
dung n&#7841;p t&#7889;t &#7903; li&#7873;u 100 mg h&#7857;ng ngày ho&#7863;c
th&#7845;p h&#417;n. Nh&#7919;ng ph&#7843;n &#7913;ng có h&#7841;i th&#432;&#7901;ng
g&#7863;p ch&#7911; y&#7871;u &#7903; da, m&#7855;t và &#273;&#432;&#7901;ng
tiêu hóa.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Th&#432;&#7901;ng g&#7863;p, ADR &gt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Da: Khô da, n&#7893;i ban, ng&#7913;a.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tiêu hóa: Nôn, bu&#7891;n nôn, &#7881;a ch&#7843;y,
&#273;au b&#7909;ng. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ph&#7843;n &#7913;ng khác: Thay &#273;&#7893;i màu da,
phân và n&#432;&#7899;c ti&#7875;u &#273;&#7893;i màu.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ít g&#7863;p, 1/1000 &lt; ADR &lt; 1/100 <o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tim m&#7841;ch: Phù, &#273;au m&#7841;ch.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Th&#7847;n kinh trung &#432;&#417;ng: Chóng m&#7863;t,
hoa m&#7855;t, bu&#7891;n ng&#7911;, m&#7879;t m&#7887;i, &#273;au &#273;&#7847;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tiêu hóa: T&#7855;c ru&#7897;t, ch&#7843;y máu
&#273;&#432;&#7901;ng tiêu hóa, chán &#259;n, táo bón, sút cân.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Gan: Viêm gan, vàng da, t&#259;ng albumin, bilirubin và
AST trong huy&#7871;t thanh.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Li&#7873;u l&#432;&#7907;ng và cách
dùng <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ng&#432;&#7901;i l&#7899;n:<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ði&#7873;u tr&#7883; t&#7845;t c&#7843; các th&#7875;
phong: Li&#7873;u th&#432;&#7901;ng dùng cho ng&#432;&#7901;i l&#7899;n là 50 -
100 mg u&#7889;ng 1 l&#7847;n hàng ngày ph&#7889;i h&#7907;p v&#7899;i m&#7897;t
ho&#7863;c nhi&#7873;u thu&#7889;c kháng khu&#7849;n khác, t&#7889;i thi&#7875;u
trong 2 n&#259;m. <b><o:p></o:p></b></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Phác &#273;&#7891; &#273;i&#7873;u tr&#7883; g&#7847;n
&#273;ây c&#7911;a T&#7893; ch&#7913;c Y t&#7871; Th&#7871; gi&#7899;i &#273;&#7889;i
v&#7899;i ng&#432;&#7901;i l&#7899;n: 50 mg, ngày u&#7889;ng 1 l&#7847;n, c&#7897;ng
thêm li&#7873;u 300 mg, m&#7897;t l&#7847;n/tháng. C&#7843;i thi&#7879;n lâm
sàng có th&#7875; phát hi&#7879;n &#273;&#432;&#7907;c sau 1 - 3 tháng và
th&#432;&#7901;ng rõ ràng sau 6 tháng &#273;i&#7873;u tr&#7883;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ði&#7873;u tr&#7883; phong do &#273;a tr&#7921;c khu&#7849;n:
phác &#273;&#7891; &#273;&#432;&#7907;c T&#7893; ch&#7913;c Y t&#7871; th&#7871;
gi&#7899;i khuy&#7871;n cáo dùng ph&#7889;i h&#7907;p v&#7899;i m&#7897;t ho&#7863;c
nhi&#7873;u thu&#7889;c ch&#7889;ng phong: clofazimin (50 mg hàng ngày c&#7897;ng
thêm li&#7873;u 300 mg tháng m&#7897;t l&#7847;n), dapson (100 mg hàng ngày) và
rifampin (600 mg m&#7897;t l&#7847;n hàng tháng). Ði&#7873;u tr&#7883; ít nh&#7845;t
2 n&#259;m ho&#7863;c &#273;&#7871;n khi ph&#7871;t kính b&#7879;nh ph&#7849;m
trên da âm tính. <b><o:p></o:p></b></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>B&#7879;nh phong u: 100 - 200 mg/ngày, dùng t&#7899;i 3
tháng ho&#7863;c lâu h&#417;n, sau &#273;ó gi&#7843;m d&#7847;n cho t&#7899;i
li&#7873;u th&#7845;p nh&#7845;t có hi&#7879;u qu&#7843; (thí d&#7909; t&#7899;i
100 mg/ngày), gi&#7843;m càng s&#7899;m càng t&#7889;t sau khi &#273;ã ki&#7875;m
soát &#273;&#432;&#7907;c giai &#273;o&#7841;n k&#7883;ch phát.<b><o:p></o:p></b></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Nhi&#7877;m ph&#7913;c h&#7907;p <i>Mycobacterium avium</i>:
&#273;i&#7873;u tr&#7883; ph&#7889;i h&#7907;p dùng clofazimin 100mg, 1 - 3 l&#7847;n/ngày,
cùng v&#7899;i thu&#7889;c ch&#7889;ng <i>Mycobacterium </i>khác.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tr&#7867; em:</span></i><span lang=DE style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana;mso-ansi-language:DE'> 1 mg/kg/ngày,
ph&#7889;i h&#7907;p v&#7899;i dapson và rifampin.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Dùng &#273;&#7891;ng th&#7901;i clofazimin không &#7843;nh
h&#432;&#7903;ng &#273;&#7871;n d&#432;&#7907;c &#273;&#7897;ng h&#7885;c c&#7911;a
dapson, nh&#432;ng có b&#7857;ng ch&#7913;ng là dapson có th&#7875; làm gi&#7843;m
ho&#7863;c m&#7845;t m&#7897;t vài tác d&#7909;ng ch&#7889;ng viêm c&#7911;a
clofazimin, nên c&#7847;n ph&#7843;i t&#259;ng li&#7873;u khi dùng cùng v&#7899;i
dapson so v&#7899;i khi dùng clofazimin &#273;&#417;n &#273;&#7897;c. Tuy
nhiên, cho t&#7899;i nay v&#7851;n ch&#432;a có b&#7857;ng ch&#7913;ng
clofazimin và dapson c&#7843;n tr&#7903; l&#7851;n nhau v&#7873; tác d&#7909;ng
ch&#7889;ng <i>Mycobacterium</i>.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Clofazimin có th&#7875; làm gi&#7843;m t&#7889;c &#273;&#7897;
h&#7845;p thu rifampin, làm rifampin ch&#7853;m &#273;&#7841;t t&#7899;i n&#7891;ng
&#273;&#7897; &#273;&#7881;nh trong huy&#7871;t t&#432;&#417;ng, nh&#432;ng
không &#7843;nh h&#432;&#7903;ng &#273;&#7871;n n&#7891;ng &#273;&#7897; và n&#7917;a
&#273;&#7901;i c&#7911;a rifampin trong huy&#7871;t t&#432;&#417;ng ho&#7863;c
th&#7843;i tr&#7915; rifampin qua n&#432;&#7899;c ti&#7875;u. Vi&#7879;c
&#273;i&#7873;u tr&#7883; ph&#7889;i h&#7907;p clofazimin, dapson và rifampin v&#7851;n
&#273;&#432;&#7907;c khuyên dùng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Dùng isoniazid &#273;&#7891;ng th&#7901;i có th&#7875;
làm t&#259;ng n&#7891;ng &#273;&#7897; clofazimin trong n&#432;&#7899;c ti&#7875;u,
huy&#7871;t t&#432;&#417;ng và gi&#7843;m n&#7891;ng &#273;&#7897; thu&#7889;c
trên da.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Ð&#7897; &#7893;n &#273;&#7883;nh và
b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>B&#7843;o qu&#7843;n nang clofazimin trong l&#7885; kín,
tránh &#7849;m, &#7903; nhi&#7879;t &#273;&#7897; 30<sup>o</sup>C ho&#7863;c th&#7845;p
h&#417;n.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Quá li&#7873;u và x&#7917; trí <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Lo&#7841;i thu&#7889;c kh&#7887;i d&#7841; dày b&#7857;ng
cách gây nôn ho&#7863;c r&#7917;a d&#7841; dày. Ði&#7873;u tr&#7883; tri&#7879;u
ch&#7913;ng và h&#7895; tr&#7907;. <o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Thông tin qui ch&#7871;<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Clofazimin có trong danh m&#7909;c thu&#7889;c thi&#7871;t
y&#7871;u Vi&#7879;t Nam ban hành l&#7847;n th&#7913; 4 n&#259;m 1999.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Thu&#7889;c ph&#7843;i &#273;&#432;&#7907;c kê
&#273;&#417;n và bán theo &#273;&#417;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Clofazimin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:45 GMT -->
</html>
